This study is the first to demonstrate that Rictor plays an important role in melanoma VM formation by regulating the phosphorylation of AKT and its downstream effectors, MMP‐2/9, indicating that Rictor may be a potential biomarker for VM formation in melanoma and can be used to predict the prognosis of melanoma patients. The gene discussed is RICTOR; the disease is melanoma.